Bushra Sumra’s career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

African National regulatory agencies (NRAs) under the World Health Organisation’s (WHO) maturity level 3, have signed a ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on delivering therapeutics through effective oral delivery, announced today that it has received revised regulatory guidance for LPCN ...

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously ...

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Carlos, of Glasgow, struggled for decades with the “constant never-ending ache” of neuropathic pain and episodes of agonising ...

Colorado's cannabis testing loopholes have led to consumers being deceived about the safety of the products they buy, with ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...